New product [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-11 16:34 (464 d 11:00 ago) – Posting: # 21256
Views: 3,417

» » Both the APIs are registered as individual products in market and we are just combining both. Why would you call it as a new product [...]
» Because that's what it is. You have to distinguish API and formulation. This will be a new combination of two existing API.

Dear Ohlbe,

Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?

Edit: Please don’t shout[Helmut]

Complete thread:

 Admin contact
21,529 posts in 4,499 threads, 1,523 registered users;
online 18 (0 registered, 18 guests [including 2 identified bots]).
Forum time: Saturday 04:34 CEST (Europe/Vienna)

Anyone who has never made a mistake
has never tried anything new.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz